177 related articles for article (PubMed ID: 21755189)
1. Nebulizers in cystic fibrosis: a source of bacterial contamination in cystic fibrosis patients?
Brzezinski LX; Riedi CA; Kussek P; Souza HH; Rosário N
J Bras Pneumol; 2011; 37(3):341-7. PubMed ID: 21755189
[TBL] [Abstract][Full Text] [Related]
2. Effect that an educational program for cystic fibrosis patients and caregivers has on the contamination of home nebulizers.
Della Zuana A; Garcia Dde O; Juliani RC; Silva Filho LV
J Bras Pneumol; 2014; 40(2):119-27. PubMed ID: 24831395
[TBL] [Abstract][Full Text] [Related]
3. Microbiological contamination of nebulizers used by cystic fibrosis patients: an underestimated problem.
Riquena B; Monte LFV; Lopes AJ; Silva-Filho LVRFD; Damaceno N; Aquino EDS; Marostica PJC; Ribeiro JD
J Bras Pneumol; 2019 May; 45(3):e20170351. PubMed ID: 31166553
[TBL] [Abstract][Full Text] [Related]
4. Microbial contamination of home nebulizers in children with cystic fibrosis and clinical implication on the number of pulmonary exacerbations.
Tabatabaii SA; Khanbabaee G; Sadr S; Farahbakhsh N; Aghdam MK; Lotfollahzadeh S; Hosseini A; Dara N; Nanbakhsh M; Gorji FA
BMC Pulm Med; 2020 Feb; 20(1):33. PubMed ID: 32028925
[TBL] [Abstract][Full Text] [Related]
5. Microbial contamination of nebulizers in the home treatment of cystic fibrosis.
Blau H; Mussaffi H; Mei Zahav M; Prais D; Livne M; Czitron BM; Cohen HA
Child Care Health Dev; 2007 Jul; 33(4):491-5. PubMed ID: 17584406
[TBL] [Abstract][Full Text] [Related]
6. Home nebulizer use among patients with cystic fibrosis.
Rosenfeld M; Emerson J; Astley S; Joy P; Williams-Warren J; Standaert TA; Yim DL; Crist D; Thykkuttathil M; Torrence M; FitzSimmons S; Ramsey B
J Pediatr; 1998 Jan; 132(1):125-31. PubMed ID: 9470013
[TBL] [Abstract][Full Text] [Related]
7. In vitro evaluation of efficacy of 5 methods of disinfection on mouthpieces and facemasks contaminated by strains of cystic fibrosis patients.
Reychler G; Aarab K; Van Ossel C; Gigi J; Simon A; Leal T; Lebecque P
J Cyst Fibros; 2005 Sep; 4(3):183-7. PubMed ID: 16046195
[TBL] [Abstract][Full Text] [Related]
8. Microbiologic contamination study of nebulizers after aerosol therapy in patients with cystic fibrosis.
Vassal S; Taamma R; Marty N; Sardet A; d'athis P; Brémont F; Dalphin ML; Plésiat P; Rault G; Thubert J; Dominique S; Lemeland JF; Derelle J; Blech MF; Roussey M; Perrin M; Sautegeau A
Am J Infect Control; 2000 Oct; 28(5):347-51. PubMed ID: 11029133
[TBL] [Abstract][Full Text] [Related]
9. Soluble squalamine tablets for the rapid disinfection of home nebulizers of cystic fibrosis patients.
Djouhri-Bouktab L; Alhanout K; Andrieu V; Stremler N; Dubus JC; Raoult D; Rolain JM; Brunel JM
J Cyst Fibros; 2012 Dec; 11(6):555-9. PubMed ID: 22727722
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of different steam disinfection protocols for cystic fibrosis nebulizers.
Hohenwarter K; Prammer W; Aichinger W; Reychler G
J Cyst Fibros; 2016 Jan; 15(1):78-84. PubMed ID: 26233897
[TBL] [Abstract][Full Text] [Related]
11. A day in the life of a nebulizer: surveillance for bacterial growth in nebulizer equipment of children with cystic fibrosis in the hospital setting.
O'Malley CA; VandenBranden SL; Zheng XT; Polito AM; McColley SA
Respir Care; 2007 Mar; 52(3):258-62. PubMed ID: 17328823
[TBL] [Abstract][Full Text] [Related]
12. Impact of hypochlorite-based disinfection on bacterial contamination of cystic fibrosis patients' home-nebulisers.
Reychler G; Leonard A; Van Ossel C; Godding V; Gigi J; Simon A; Lebecque P
J Hosp Infect; 2009 Aug; 72(4):351-7. PubMed ID: 19596489
[TBL] [Abstract][Full Text] [Related]
13. Nebulizer cleaning and disinfection practices in families with cystic fibrosis: The relationship between attitudes, practice and microbe colonization.
Murray TS; O'Rourke TK; Feinn R; Drapeau G; Collins MS
J Cyst Fibros; 2019 Nov; 18(6):823-828. PubMed ID: 31126899
[TBL] [Abstract][Full Text] [Related]
14. Frequency of contamination of single-patient-use nebulizers over time.
Weber DJ; Gergen MF; Sickbert-Bennett EE; Short KA; Lanza-Kaduce KE; Rutala WA
Infect Control Hosp Epidemiol; 2014 Dec; 35(12):1543-6. PubMed ID: 25419779
[TBL] [Abstract][Full Text] [Related]
15. Cleaning and infection control of airway clearance devices used by CF patients.
Manor E; Gur M; Geffen Y; Bentur L
Chron Respir Dis; 2017 Nov; 14(4):370-376. PubMed ID: 28513198
[TBL] [Abstract][Full Text] [Related]
16. Bacterial Surface Detachment during Nebulization with Contaminated Reusable Home Nebulizers.
Harris JC; Collins MS; Huang PH; Schramm CM; Nero T; Yan J; Murray TS
Microbiol Spectr; 2022 Feb; 10(1):e0253521. PubMed ID: 35107362
[TBL] [Abstract][Full Text] [Related]
17. Contamination of the nebulization systems used in the prophylaxis with amphotericin B nebulized in lung transplantation.
Monforte V; Román A; Gavaldà J; Bravo C; Rodriguez V; Ferrer A; Pahissa A; Morell F
Transplant Proc; 2005 Nov; 37(9):4056-8. PubMed ID: 16386625
[TBL] [Abstract][Full Text] [Related]
18. Low bacterial contamination of nebulizers in home treatment of cystic fibrosis patients.
Jakobsson BM; Onnered AB; Hjelte L; Nyström B
J Hosp Infect; 1997 Jul; 36(3):201-7. PubMed ID: 9253701
[TBL] [Abstract][Full Text] [Related]
19. Microbial colonization of nebulizers used by asthmatic children.
Cohen HA; Kahan E; Cohen Z; Sarrell M; Beni S; Grosman Z; Ashkenazi S
Pediatr Int; 2006 Oct; 48(5):454-8. PubMed ID: 16970782
[TBL] [Abstract][Full Text] [Related]
20. Low level of bacterial contamination of mist tents used in home treatment of cystic fibrosis patients.
Jakobsson B; Hjelte L; Nyström B
J Hosp Infect; 2000 Jan; 44(1):37-41. PubMed ID: 10633052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]